The association of E4 carriers with dyslipidemia is not so clear; this isoform is preferentially incorporated into VLDL, and this could compete with the uptake of LDL by the LDL receptor, thus decreasing the hepatic LDL uptake and prolonging its presence in circulation. This evidence concerns the gene LDLR and metabolic syndrome.